Flagship explainer

How CORCEPT THERAPEUTICS INC makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$761M · 100%Cost of revenue$13M · 2%Gross profit$748M · 98%Operating income$44.8M · 6%Income before tax$66.5M · 9%Income tax−$33.2M · −4%Net income$99.7M · 13%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$761M100%
Cost of revenue$13M2%
$748M98%
$44.8M6%
Income before tax$66.5M9%
Income tax−$33.2M−4%
$99.7M13%
Source: · event Dec 31, 2025 · retrieved Oct 15, 2026 · annual-row source set
Embed this chart

View the full CORCEPT THERAPEUTICS INC analysis at Buy Like Buffett